AU2001249423A1 - 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor - Google Patents

38692 and 21117, novel dual specificity phosphatase molecules and uses therefor

Info

Publication number
AU2001249423A1
AU2001249423A1 AU2001249423A AU4942301A AU2001249423A1 AU 2001249423 A1 AU2001249423 A1 AU 2001249423A1 AU 2001249423 A AU2001249423 A AU 2001249423A AU 4942301 A AU4942301 A AU 4942301A AU 2001249423 A1 AU2001249423 A1 AU 2001249423A1
Authority
AU
Australia
Prior art keywords
dual specificity
uses therefor
novel dual
specificity phosphatase
phosphatase molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249423A
Inventor
Rachel E Meyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001249423A1 publication Critical patent/AU2001249423A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001249423A 2000-03-24 2001-03-23 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor Abandoned AU2001249423A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19185800P 2000-03-24 2000-03-24
US60191858 2000-03-24
PCT/US2001/009477 WO2001073059A2 (en) 2000-03-24 2001-03-23 38692 and 21117: dual specificity phosphatase molecules and uses therefor

Publications (1)

Publication Number Publication Date
AU2001249423A1 true AU2001249423A1 (en) 2001-10-08

Family

ID=22707181

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001247782A Abandoned AU2001247782A1 (en) 2000-03-24 2001-03-22 18221, dual specificity phosphatase and uses thereof
AU2001249423A Abandoned AU2001249423A1 (en) 2000-03-24 2001-03-23 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001247782A Abandoned AU2001247782A1 (en) 2000-03-24 2001-03-22 18221, dual specificity phosphatase and uses thereof

Country Status (4)

Country Link
US (2) US20020065406A1 (en)
EP (2) EP1268818A2 (en)
AU (2) AU2001247782A1 (en)
WO (2) WO2001073060A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479270B1 (en) * 2000-02-14 2002-11-12 Pe Corporation (Ny) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
AU2001294744A1 (en) * 2000-09-26 2002-04-08 Ceptyr, Inc. Dsp-16 dual-specificity phosphatase
DE10056802B4 (en) * 2000-11-14 2005-06-16 Epigenomics Ag Method for the detection of methylation conditions for toxicological diagnostics
MXPA03005436A (en) * 2000-12-20 2004-05-05 Bristol Myers Squibb Co Polynucleotides encoding novel human phosphatases.
JP2006500413A (en) * 2002-09-27 2006-01-05 デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング SKRP, astry, string, VACM related to metabolic control
CN103451246B (en) 2004-04-22 2018-02-16 联邦科学技术研究组织 With recombinant cell synthesis of long-chain polyunsaturated fatty acids
BRPI0510132A (en) 2004-04-22 2007-10-02 Commw Scient Ind Res Org long chain polyunsaturated fatty acid synthesis by recombinant cells
EP2290071B1 (en) * 2004-05-28 2014-12-31 Asuragen, Inc. Methods and compositions involving microRNA
DK2302055T3 (en) 2004-11-12 2014-10-13 Asuragen Inc Methods and compositions involving miRNA and miRNA inhibitor molecules
BRPI0716075A2 (en) 2006-08-29 2013-08-06 Commw Scient Ind Res Org Fatty Acid Synthesis
EP2115138A2 (en) * 2006-09-19 2009-11-11 Asuragen, Inc. Micrornas differentially expressed in pancreatic diseases and uses thereof
CA2663962A1 (en) * 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
CA2671294A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Mir-21 regulated genes and pathways as targets for therapeutic intervention
CN101622348A (en) * 2006-12-08 2010-01-06 奥斯瑞根公司 Gene and the approach regulated as the miR-20 of targets for therapeutic intervention
CA2671299A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Functions and targets of let-7 micro rnas
CA2671270A1 (en) * 2006-12-29 2008-07-17 Asuragen, Inc. Mir-16 regulated genes and pathways as targets for therapeutic intervention
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090131354A1 (en) * 2007-05-22 2009-05-21 Bader Andreas G miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
AU2008261951A1 (en) * 2007-06-08 2008-12-18 Asuragen, Inc. miR-34 regulated genes and pathways as targets for therapeutic intervention
WO2009036332A1 (en) 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
WO2009052386A1 (en) * 2007-10-18 2009-04-23 Asuragen, Inc. Micrornas differentially expressed in lung diseases and uses thereof
WO2009070805A2 (en) * 2007-12-01 2009-06-04 Asuragen, Inc. Mir-124 regulated genes and pathways as targets for therapeutic intervention
WO2009086156A2 (en) * 2007-12-21 2009-07-09 Asuragen, Inc. Mir-10 regulated genes and pathways as targets for therapeutic intervention
WO2009100430A2 (en) * 2008-02-08 2009-08-13 Asuragen, Inc miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
EP2268832A2 (en) * 2008-03-06 2011-01-05 Asuragen, INC. Microrna markers for recurrence of colorectal cancer
WO2009154835A2 (en) * 2008-03-26 2009-12-23 Asuragen, Inc. Compositions and methods related to mir-16 and therapy of prostate cancer
WO2009137807A2 (en) 2008-05-08 2009-11-12 Asuragen, Inc. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
US20100179213A1 (en) * 2008-11-11 2010-07-15 Mirna Therapeutics, Inc. Methods and Compositions Involving miRNAs In Cancer Stem Cells
CN107858204B (en) 2008-11-18 2021-10-29 联邦科学技术研究组织 Enzymes and methods for producing omega-3 fatty acids
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
ES2636487T3 (en) 2012-06-15 2017-10-05 Commonwealth Scientific And Industrial Research Organisation Production of long chain polyunsaturated fatty acids in plant cells
EA037817B1 (en) 2013-12-18 2021-05-25 Коммонвелт Сайнтифик Энд Индастриэл Рисерч Организэйшн Extracted plant lipid comprising long chain polyunsaturated fatty acids
EP3160482A4 (en) 2014-06-27 2018-02-14 Commonwealth Scientific and Industrial Research Organisation Lipid comprising docosapentaenoic acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516059D0 (en) * 1995-08-04 1995-10-04 Medical Res Council Novel genes and proteins
AU8479498A (en) * 1997-07-08 1999-02-08 Cold Spring Harbor Laboratory Dual specificity phosphatase and methods of use
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
JP2002540795A (en) * 1999-04-07 2002-12-03 セプティア， インコーポレイテッド DSP-4 bispecific MAP kinase phosphatase
WO2001012819A2 (en) * 1999-08-13 2001-02-22 Sugen, Inc. Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
CA2383927A1 (en) * 1999-09-15 2001-03-22 Incyte Genomics, Inc. Protein phosphatase and kinase proteins
JP2003517836A (en) 1999-12-21 2003-06-03 スージェン・インコーポレーテッド Mammalian protein phosphatase

Also Published As

Publication number Publication date
WO2001073060A9 (en) 2002-12-19
WO2001073060A2 (en) 2001-10-04
WO2001073059A3 (en) 2002-06-20
WO2001073060A3 (en) 2002-04-04
WO2001073059A2 (en) 2001-10-04
EP1268818A2 (en) 2003-01-02
US20020065406A1 (en) 2002-05-30
EP1319078A2 (en) 2003-06-18
AU2001247782A1 (en) 2001-10-08
US6664089B2 (en) 2003-12-16
US20020034807A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU2001249423A1 (en) 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor
AU2113599A (en) Human protease molecules
AU2001271427A1 (en) Novel proteases
AUPQ339899A0 (en) Novel molecules
AU2001286976A1 (en) Novel autoinducer molecules and uses therefor
AU2001259434A1 (en) Calcitonin-related molecules
AU2001275990A1 (en) 16816 and 16839, novel human phospholipase c molecules and uses therefor
AU2002217384A1 (en) Anti-allergic complex molecules
AU2001232132A1 (en) Novel assay
AU2001270532A1 (en) Novel toxins
AU2001240793A1 (en) Novel assay
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AU2002216946A1 (en) Modified pna molecules
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU2001257404A1 (en) 2246, novel protein kinase molecules and uses therefor
AU2001245974A1 (en) 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
AU2001239897A1 (en) 18232, a dual specificity phosphatase
AU2002236595A1 (en) Enzymes
AU2001253386A1 (en) Haplotypes of the impdh2 gene
AU2001240017A1 (en) Human enzyme molecules
AU2001253907A1 (en) 27960, a novel ubiquitin conjugating enzyme family member and uses therefor
AUPR166900A0 (en) Novel molecules
AUPQ632700A0 (en) Novel molecules
AU2002224556A1 (en) Adhesion molecules
AU2002211597A1 (en) 8843, a human dual specificity phosphatase family member and uses therefor